Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, other mental health clinicians working within addiction. This activity is accredited for Physicians, Physician Assistants, Social Workers, Pharmacists, and Healthcare teams.
Webinar Description: The number of older adults is projected to exceed 72.1 million people by 2030 and members of the baby boomer generation have the highest rates of early life substance use which increases likelihood of substance use in later life. With rates of SUDs growing in older individuals, this population is experiencing mood and anxiety disorders, sleep disorders, cognitive impairments, sleep disruption, hepatic complications, and greater physical disability as co-morbid symptoms of substance use and aging. This webinar aims to improve awareness of the occurrence and impact of SUD as well as teach geriatric SUD screening tools. Finally, the webinar will offer recommendations for pharmacologic and psychosocial treatments for SUD in older adults.
- Gain awareness of the occurrence and impact of substance use disorders (SUDs) in late-life.
- Employ appropriate screening tools to identify SUD in late-life.
- Identify how SUDs in late-life differ from SUDs in younger adults.
- Adapt pharmacologic treatments for older adults with SUD.
- Implement recommendations for psychosocial treatments for the treatment of SUD.
Continuing Education information:
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Designation Statement
American Academy of Addiction Psychiatry designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Designation Statement
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1.5 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Social Work Designation Statement
As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1.5 continuing education credits.
Pharmacy Designation Statement
This course has been approved for 1.5 hours of pharmacy continuing education credits. The approval number issued is Universal Activity Number: UAN JA4008192-0000-23-031-L01-P.
Interprofessional Continuing Education (IPCE) Designation Statement
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education credits for learning and change.
Other Health Professionals
Participants will receive a Certificate of Attendance stating this program is designated for 1.5 AMA PRA Category 1 Credits™.